Skip to main content
Loading

Policy Outlook: Navigating a New Congress and Executive Branch

February 11, 2025
With the election of a new Congress, President, and agency leadership, there are questions about the trajectory of policies and guidelines and what will change for the biotech industry. As new priorities emerge, understanding the landscape and leadership is top of mind. This session will look to offer an inside the Beltway perspective on the year ahead in Washington and allow for a discussion with company leaders, policy experts, and investors to highlight priorities moving forward.​
Moderator
Anna Abram, Senior Advisor, Health Care Policy and Legislation - Akin
Speakers
Lindsay Androski, President and CEO - Roivant Social Ventures
Remy Brim, Principal, Health Care Practice Head - BGR Government Affairs, LLC
Pete Norman, Senior Vice President, Policy and Government Relations - Alkermes, Inc.
View all 2025 Program
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP